Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03352063 · ClinicalTrials.gov registry record · NA

Prolonged Sitting on Responses to Short-Term Exercise Training

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03352063: Completed NA study, sponsored by University of Texas at Austin.

NCT03352063 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03352063, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

Prolonged sitting has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of prolonged sitting on response to a HFTT after a short term training period.

Primary Outcome

Areas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test

Interventions

  • BEHAVIORAL Prolonged sitting with exercise
  • BEHAVIORAL Active walking with exercise.

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-07-17
Est. Completion 2020-05-30
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT03352063 record still lists

NCT03352063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Prolonged sitting with exercise is the first listed.

NCT03352063 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03352063 about?

NCT03352063 is a clinical study titled "Prolonged Sitting on Responses to Short-Term Exercise Training". Prolonged sitting has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of prolonged sitting on response to a HFTT after a short term training period.

What is the current status of trial NCT03352063?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-07-17. Estimated completion is 2020-05-30.

What interventions are being tested in trial NCT03352063?

The interventions under investigation include: Prolonged sitting with exercise (BEHAVIORAL), Active walking with exercise. (BEHAVIORAL).

Who is sponsoring clinical trial NCT03352063?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03352063's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03352063, the US trial registry maintained by the National Library of Medicine. NCT03352063 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.